Moderna, Inc. - 10-Q Filing
Moderna reports Q3 2026 financial results including product sales across COVID-19 and RSV segments.
Tickers: $MRNA
More Regulatory news
- Solana Co - 10-Q Filing
- Solana Co - 8-K Filing
- DeFi Development Corp. - 8-K Filing
- Stablecoin Development Corp - 8-K Filing
- BCP Investment Corp - 8-K Filing
- OneWater Marine Inc. - 8-K Filing
- Moleculin Biotech, Inc. - 8-K Filing
- Investcorp Credit Management BDC, Inc. - 8-K Filing
- Presurance Holdings, Inc. - 10-Q Filing
- Corteva, Inc. - 8-K Filing